No clinical trial has shown soursop treats disease in humans, and there is no proven onset time.
Soursop — Annona muricata, also sold as graviola — has no established onset time, no standard dose, and no proven therapeutic effect in people. Human trials have not established that it works, so nobody can say when it “kicks in.”
Below: animal data versus human data, the plant parts carrying real risk, and key interactions.
Why No Onset Time Exists
Every “starts working in X days” claim traces to lab dishes or rodents, which cannot produce a human timeline — they cannot show whether a substance works in people, how fast, or at what dose. Animal studies on blood sugar reported reductions after roughly 28–48 days, but that describes rats, not you.
The FDA flagged the claims directly, not the fruit. Warning letters dated April 17, 2017 state that disease-treatment claims on products including “Sour Sop Capsules,” “Sour Sop Tea Bags,” and “Sour Sop Leaves” made those items drugs under federal law, not generally recognized as safe and effective for the promoted uses.
Blood Sugar, Blood Pressure, And Other Proposed Uses
Blood sugar and blood pressure effects rest on animal and limited nonclinical studies: no reliable human onset time or therapeutic dose. Cancer has no human clinical evidence. Inflammation, infection, and antioxidant claims are mostly lab or animal work, with human data too thin to judge benefit or timing — a starting point, not a schedule.
One common mix-up: eating ripe soursop as food differs from drinking concentrated leaf tea or taking powdered leaf, extract, or capsules. Composition and safety vary by plant part and preparation, and no standardized, evidence-based product specification or dosing regimen exists.
| Proposed Use | Strongest Evidence | Human Onset Time |
|---|---|---|
| Cancer | None in humans; FDA-warned marketing | Not established |
| Blood sugar | Animal studies (~28–48 days) | Not established |
| Blood pressure | Animal and limited nonclinical data | Not established |
| Inflammation | Lab or animal studies | Not established |
| Infection | Lab or animal studies | Not established |
| Antioxidant effects | Lab studies; insufficient human data | Not established |
| General “wellness” | No clinical-trial support | Not established |
The FDA keeps a list of illegally sold cancer treatments naming soursop products among items never reviewed for safety or efficacy.
What To Watch Before You Take Any
Safety concerns, not timing, are the real story. Talk to a clinician first if considering medicinal soursop — especially with cancer, Parkinson disease, diabetes, low blood pressure, liver disease, pregnancy, or upcoming nuclear imaging.
- Never use soursop in place of prescribed cancer treatment or other medical care.
- Avoid the seeds; they may be toxic.
- Concentrated preparations raise neurological concerns: alkaloids extracted from graviola have been linked to neuronal dysfunction and possible Parkinson-like effects, so people with Parkinson disease should avoid medicinal amounts and skip leaf decoctions entirely.
- Large single doses may cause nausea and vomiting.
- Blood pressure can drop — matters if yours runs low or you take antihypertensives.
- Blood sugar may fall or interact with diabetes medicines, creating hypoglycemia risk.
- Nuclear-imaging scans can be affected since soursop may reduce absorption of the radioactive substances used. Tell your clinician before imaging.
- Pregnancy and breastfeeding safety is inadequately studied; safety data for children is insufficient — avoid prolonged soursop-tea use.
- High-dose extracts produced liver toxicity in animal research; human safety thresholds are not established.
Anyone weighing a daily capsule habit can compare timing and dosage considerations here before deciding on a schedule.
Mistakes That Skew The Picture
Most bad advice comes from treating test-tube or animal results as proof of a human effect and predictable schedule. A second error: assuming bigger doses or stronger extracts work faster — the evidence doesn’t support that, and high-dose extracts caused liver toxicity in animals. “Natural,” “organic,” and supplement wording does not mean FDA approval or proven efficacy; the agency said the marketed disease-treatment products behind its warnings lacked required evidence and approval. Also disclose soursop use before blood-pressure, diabetes, neurological, or nuclear-imaging care.
The absence of a human onset time is not a research gap awaiting filling — the human evidence needed to produce one does not exist.
Common Questions
Can graviola shrink a tumor in a set number of weeks?
No reliable evidence supports that. Human cancer data are lacking, and the FDA has warned sellers against marketing graviola for disease treatment. Pursue evidence-based care and discuss any supplement with your oncology team.
Is soursop tea safer than capsules or extracts?
Not automatically. Safety and chemical makeup differ by plant part and preparation, with no standardized specification for any form. Leaf decoctions carry the same neurological caveats as extracts, and seeds should be avoided because they may be toxic.
Does soursop interact with prescription medication?
It can. Soursop may lower blood pressure and blood sugar, compounding antihypertensives and diabetes medicines, and may interfere with nuclear-imaging scans by reducing absorption of the radioactive substances used. Disclose any soursop use before treatment or imaging.
Sources
- US Food and Drug Administration. “Illegally Sold Cancer Treatments.” Lists soursop products among unapproved cancer treatments.
- Drugs.com. “Soursop.” Natural product monograph covering evidence, dosing gaps, and safety.
- CANSA. “Fact Sheet and Position Statement on Soursop (Graviola).” Reviews proposed uses and cautions.